Global PDGFR Inhibitors Market Growth (Status and Outlook) 2024-2030

August 2024 | 91 pages | ID: G8B9A17AACA2EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The FDA has approved more than 10 PDGFR multikinase antagonists for the treatment of various tumor diseases and pulmonary fibrosis. Recombinant PDGF is used to help treat chronic ulcers, orthopedic surgery and periodontal disease to stimulate bone regeneration and repair. When PDGF is used alone or in combination with other growth factors to stimulate soft and hard tissue healing.

The global PDGFR Inhibitors market size is projected to grow from US$ 2424 million in 2024 to US$ 3735 million in 2030; it is expected to grow at a CAGR of 7.5% from 2024 to 2030.

LPI (LP Information)' newest research report, the “PDGFR Inhibitors Industry Forecast” looks at past sales and reviews total world PDGFR Inhibitors sales in 2022, providing a comprehensive analysis by region and market sector of projected PDGFR Inhibitors sales for 2023 through 2029. With PDGFR Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PDGFR Inhibitors industry.

This Insight Report provides a comprehensive analysis of the global PDGFR Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on PDGFR Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PDGFR Inhibitors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PDGFR Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PDGFR Inhibitors.

United States market for PDGFR Inhibitors is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for PDGFR Inhibitors is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for PDGFR Inhibitors is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key PDGFR Inhibitors players cover Novartis, Eli Lilly, Eisai, Pfizer, GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of PDGFR Inhibitors market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Capsules
• Tablets
• Others

Segmentation by Application:

• Hospitals
• Clinics

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Segmentation by Type:

• Capsules
• Tablets
• Others

Segmentation by Application:

• Hospitals
• Clinics

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• Eli Lilly
• Eisai
• Pfizer
• GSK
• Boehringer Ingelheim
• Il-Yang Pharmaceutical
• Takeda
• Bayer
• Bristol-Myers Squibb

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global PDGFR Inhibitors Market Size 2019-2030
  2.1.2 PDGFR Inhibitors Market Size CAGR by Region (2019 VS 2023 VS 2030)
  2.1.3 World Current & Future Analysis for PDGFR Inhibitors by Country/Region, 2019, 2023 & 2030
2.2 PDGFR Inhibitors Segment by Type
  2.2.1 Capsules
  2.2.2 Tablets
  2.2.3 Others
2.3 PDGFR Inhibitors Market Size by Type
  2.3.1 PDGFR Inhibitors Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global PDGFR Inhibitors Market Size Market Share by Type (2019-2024)
2.4 PDGFR Inhibitors Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
2.5 PDGFR Inhibitors Market Size by Application
  2.5.1 PDGFR Inhibitors Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global PDGFR Inhibitors Market Size Market Share by Application (2019-2024)

3 PDGFR INHIBITORS MARKET SIZE BY PLAYER

3.1 PDGFR Inhibitors Market Size Market Share by Player
  3.1.1 Global PDGFR Inhibitors Revenue by Player (2019-2024)
  3.1.2 Global PDGFR Inhibitors Revenue Market Share by Player (2019-2024)
3.2 Global PDGFR Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PDGFR INHIBITORS BY REGION

4.1 PDGFR Inhibitors Market Size by Region (2019-2024)
4.2 Global PDGFR Inhibitors Annual Revenue by Country/Region (2019-2024)
4.3 Americas PDGFR Inhibitors Market Size Growth (2019-2024)
4.4 APAC PDGFR Inhibitors Market Size Growth (2019-2024)
4.5 Europe PDGFR Inhibitors Market Size Growth (2019-2024)
4.6 Middle East & Africa PDGFR Inhibitors Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas PDGFR Inhibitors Market Size by Country (2019-2024)
5.2 Americas PDGFR Inhibitors Market Size by Type (2019-2024)
5.3 Americas PDGFR Inhibitors Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC PDGFR Inhibitors Market Size by Region (2019-2024)
6.2 APAC PDGFR Inhibitors Market Size by Type (2019-2024)
6.3 APAC PDGFR Inhibitors Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe PDGFR Inhibitors Market Size by Country (2019-2024)
7.2 Europe PDGFR Inhibitors Market Size by Type (2019-2024)
7.3 Europe PDGFR Inhibitors Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa PDGFR Inhibitors by Region (2019-2024)
8.2 Middle East & Africa PDGFR Inhibitors Market Size by Type (2019-2024)
8.3 Middle East & Africa PDGFR Inhibitors Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PDGFR INHIBITORS MARKET FORECAST

10.1 Global PDGFR Inhibitors Forecast by Region (2025-2030)
  10.1.1 Global PDGFR Inhibitors Forecast by Region (2025-2030)
  10.1.2 Americas PDGFR Inhibitors Forecast
  10.1.3 APAC PDGFR Inhibitors Forecast
  10.1.4 Europe PDGFR Inhibitors Forecast
  10.1.5 Middle East & Africa PDGFR Inhibitors Forecast
10.2 Americas PDGFR Inhibitors Forecast by Country (2025-2030)
  10.2.1 United States Market PDGFR Inhibitors Forecast
  10.2.2 Canada Market PDGFR Inhibitors Forecast
  10.2.3 Mexico Market PDGFR Inhibitors Forecast
  10.2.4 Brazil Market PDGFR Inhibitors Forecast
10.3 APAC PDGFR Inhibitors Forecast by Region (2025-2030)
  10.3.1 China PDGFR Inhibitors Market Forecast
  10.3.2 Japan Market PDGFR Inhibitors Forecast
  10.3.3 Korea Market PDGFR Inhibitors Forecast
  10.3.4 Southeast Asia Market PDGFR Inhibitors Forecast
  10.3.5 India Market PDGFR Inhibitors Forecast
  10.3.6 Australia Market PDGFR Inhibitors Forecast
10.4 Europe PDGFR Inhibitors Forecast by Country (2025-2030)
  10.4.1 Germany Market PDGFR Inhibitors Forecast
  10.4.2 France Market PDGFR Inhibitors Forecast
  10.4.3 UK Market PDGFR Inhibitors Forecast
  10.4.4 Italy Market PDGFR Inhibitors Forecast
  10.4.5 Russia Market PDGFR Inhibitors Forecast
10.5 Middle East & Africa PDGFR Inhibitors Forecast by Region (2025-2030)
  10.5.1 Egypt Market PDGFR Inhibitors Forecast
  10.5.2 South Africa Market PDGFR Inhibitors Forecast
  10.5.3 Israel Market PDGFR Inhibitors Forecast
  10.5.4 Turkey Market PDGFR Inhibitors Forecast
10.6 Global PDGFR Inhibitors Forecast by Type (2025-2030)
10.7 Global PDGFR Inhibitors Forecast by Application (2025-2030)
  10.7.1 GCC Countries Market PDGFR Inhibitors Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis PDGFR Inhibitors Product Offered
  11.1.3 Novartis PDGFR Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments
11.2 Eli Lilly
  11.2.1 Eli Lilly Company Information
  11.2.2 Eli Lilly PDGFR Inhibitors Product Offered
  11.2.3 Eli Lilly PDGFR Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Eli Lilly Main Business Overview
  11.2.5 Eli Lilly Latest Developments
11.3 Eisai
  11.3.1 Eisai Company Information
  11.3.2 Eisai PDGFR Inhibitors Product Offered
  11.3.3 Eisai PDGFR Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Eisai Main Business Overview
  11.3.5 Eisai Latest Developments
11.4 Pfizer
  11.4.1 Pfizer Company Information
  11.4.2 Pfizer PDGFR Inhibitors Product Offered
  11.4.3 Pfizer PDGFR Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Pfizer Main Business Overview
  11.4.5 Pfizer Latest Developments
11.5 GSK
  11.5.1 GSK Company Information
  11.5.2 GSK PDGFR Inhibitors Product Offered
  11.5.3 GSK PDGFR Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 GSK Main Business Overview
  11.5.5 GSK Latest Developments
11.6 Boehringer Ingelheim
  11.6.1 Boehringer Ingelheim Company Information
  11.6.2 Boehringer Ingelheim PDGFR Inhibitors Product Offered
  11.6.3 Boehringer Ingelheim PDGFR Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Boehringer Ingelheim Main Business Overview
  11.6.5 Boehringer Ingelheim Latest Developments
11.7 Il-Yang Pharmaceutical
  11.7.1 Il-Yang Pharmaceutical Company Information
  11.7.2 Il-Yang Pharmaceutical PDGFR Inhibitors Product Offered
  11.7.3 Il-Yang Pharmaceutical PDGFR Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Il-Yang Pharmaceutical Main Business Overview
  11.7.5 Il-Yang Pharmaceutical Latest Developments
11.8 Takeda
  11.8.1 Takeda Company Information
  11.8.2 Takeda PDGFR Inhibitors Product Offered
  11.8.3 Takeda PDGFR Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Takeda Main Business Overview
  11.8.5 Takeda Latest Developments
11.9 Bayer
  11.9.1 Bayer Company Information
  11.9.2 Bayer PDGFR Inhibitors Product Offered
  11.9.3 Bayer PDGFR Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Bayer Main Business Overview
  11.9.5 Bayer Latest Developments
11.10 Bristol-Myers Squibb
  11.10.1 Bristol-Myers Squibb Company Information
  11.10.2 Bristol-Myers Squibb PDGFR Inhibitors Product Offered
  11.10.3 Bristol-Myers Squibb PDGFR Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Bristol-Myers Squibb Main Business Overview
  11.10.5 Bristol-Myers Squibb Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. PDGFR Inhibitors Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. PDGFR Inhibitors Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Capsules
Table 4. Major Players of Tablets
Table 5. Major Players of Others
Table 6. PDGFR Inhibitors Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global PDGFR Inhibitors Market Size by Type (2019-2024) & ($ millions)
Table 8. Global PDGFR Inhibitors Market Size Market Share by Type (2019-2024)
Table 9. PDGFR Inhibitors Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global PDGFR Inhibitors Market Size by Application (2019-2024) & ($ millions)
Table 11. Global PDGFR Inhibitors Market Size Market Share by Application (2019-2024)
Table 12. Global PDGFR Inhibitors Revenue by Player (2019-2024) & ($ millions)
Table 13. Global PDGFR Inhibitors Revenue Market Share by Player (2019-2024)
Table 14. PDGFR Inhibitors Key Players Head office and Products Offered
Table 15. PDGFR Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global PDGFR Inhibitors Market Size by Region (2019-2024) & ($ millions)
Table 19. Global PDGFR Inhibitors Market Size Market Share by Region (2019-2024)
Table 20. Global PDGFR Inhibitors Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global PDGFR Inhibitors Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas PDGFR Inhibitors Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas PDGFR Inhibitors Market Size Market Share by Country (2019-2024)
Table 24. Americas PDGFR Inhibitors Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas PDGFR Inhibitors Market Size Market Share by Type (2019-2024)
Table 26. Americas PDGFR Inhibitors Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas PDGFR Inhibitors Market Size Market Share by Application (2019-2024)
Table 28. APAC PDGFR Inhibitors Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC PDGFR Inhibitors Market Size Market Share by Region (2019-2024)
Table 30. APAC PDGFR Inhibitors Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC PDGFR Inhibitors Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe PDGFR Inhibitors Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe PDGFR Inhibitors Market Size Market Share by Country (2019-2024)
Table 34. Europe PDGFR Inhibitors Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe PDGFR Inhibitors Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa PDGFR Inhibitors Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa PDGFR Inhibitors Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa PDGFR Inhibitors Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of PDGFR Inhibitors
Table 40. Key Market Challenges & Risks of PDGFR Inhibitors
Table 41. Key Industry Trends of PDGFR Inhibitors
Table 42. Global PDGFR Inhibitors Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global PDGFR Inhibitors Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global PDGFR Inhibitors Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global PDGFR Inhibitors Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Novartis Details, Company Type, PDGFR Inhibitors Area Served and Its Competitors
Table 47. Novartis PDGFR Inhibitors Product Offered
Table 48. Novartis PDGFR Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Novartis Main Business
Table 50. Novartis Latest Developments
Table 51. Eli Lilly Details, Company Type, PDGFR Inhibitors Area Served and Its Competitors
Table 52. Eli Lilly PDGFR Inhibitors Product Offered
Table 53. Eli Lilly PDGFR Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Eli Lilly Main Business
Table 55. Eli Lilly Latest Developments
Table 56. Eisai Details, Company Type, PDGFR Inhibitors Area Served and Its Competitors
Table 57. Eisai PDGFR Inhibitors Product Offered
Table 58. Eisai PDGFR Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Eisai Main Business
Table 60. Eisai Latest Developments
Table 61. Pfizer Details, Company Type, PDGFR Inhibitors Area Served and Its Competitors
Table 62. Pfizer PDGFR Inhibitors Product Offered
Table 63. Pfizer PDGFR Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Pfizer Main Business
Table 65. Pfizer Latest Developments
Table 66. GSK Details, Company Type, PDGFR Inhibitors Area Served and Its Competitors
Table 67. GSK PDGFR Inhibitors Product Offered
Table 68. GSK PDGFR Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. GSK Main Business
Table 70. GSK Latest Developments
Table 71. Boehringer Ingelheim Details, Company Type, PDGFR Inhibitors Area Served and Its Competitors
Table 72. Boehringer Ingelheim PDGFR Inhibitors Product Offered
Table 73. Boehringer Ingelheim PDGFR Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Boehringer Ingelheim Main Business
Table 75. Boehringer Ingelheim Latest Developments
Table 76. Il-Yang Pharmaceutical Details, Company Type, PDGFR Inhibitors Area Served and Its Competitors
Table 77. Il-Yang Pharmaceutical PDGFR Inhibitors Product Offered
Table 78. Il-Yang Pharmaceutical PDGFR Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Il-Yang Pharmaceutical Main Business
Table 80. Il-Yang Pharmaceutical Latest Developments
Table 81. Takeda Details, Company Type, PDGFR Inhibitors Area Served and Its Competitors
Table 82. Takeda PDGFR Inhibitors Product Offered
Table 83. Takeda PDGFR Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Takeda Main Business
Table 85. Takeda Latest Developments
Table 86. Bayer Details, Company Type, PDGFR Inhibitors Area Served and Its Competitors
Table 87. Bayer PDGFR Inhibitors Product Offered
Table 88. Bayer PDGFR Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Bayer Main Business
Table 90. Bayer Latest Developments
Table 91. Bristol-Myers Squibb Details, Company Type, PDGFR Inhibitors Area Served and Its Competitors
Table 92. Bristol-Myers Squibb PDGFR Inhibitors Product Offered
Table 93. Bristol-Myers Squibb PDGFR Inhibitors Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Bristol-Myers Squibb Main Business
Table 95. Bristol-Myers Squibb Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. PDGFR Inhibitors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global PDGFR Inhibitors Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. PDGFR Inhibitors Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. PDGFR Inhibitors Sales Market Share by Country/Region (2023)
Figure 8. PDGFR Inhibitors Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global PDGFR Inhibitors Market Size Market Share by Type in 2023
Figure 10. PDGFR Inhibitors in Hospitals
Figure 11. Global PDGFR Inhibitors Market: Hospitals (2019-2024) & ($ millions)
Figure 12. PDGFR Inhibitors in Clinics
Figure 13. Global PDGFR Inhibitors Market: Clinics (2019-2024) & ($ millions)
Figure 14. Global PDGFR Inhibitors Market Size Market Share by Application in 2023
Figure 15. Global PDGFR Inhibitors Revenue Market Share by Player in 2023
Figure 16. Global PDGFR Inhibitors Market Size Market Share by Region (2019-2024)
Figure 17. Americas PDGFR Inhibitors Market Size 2019-2024 ($ millions)
Figure 18. APAC PDGFR Inhibitors Market Size 2019-2024 ($ millions)
Figure 19. Europe PDGFR Inhibitors Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa PDGFR Inhibitors Market Size 2019-2024 ($ millions)
Figure 21. Americas PDGFR Inhibitors Value Market Share by Country in 2023
Figure 22. United States PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC PDGFR Inhibitors Market Size Market Share by Region in 2023
Figure 27. APAC PDGFR Inhibitors Market Size Market Share by Type (2019-2024)
Figure 28. APAC PDGFR Inhibitors Market Size Market Share by Application (2019-2024)
Figure 29. China PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 33. India PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe PDGFR Inhibitors Market Size Market Share by Country in 2023
Figure 36. Europe PDGFR Inhibitors Market Size Market Share by Type (2019-2024)
Figure 37. Europe PDGFR Inhibitors Market Size Market Share by Application (2019-2024)
Figure 38. Germany PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 39. France PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 40. UK PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa PDGFR Inhibitors Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa PDGFR Inhibitors Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa PDGFR Inhibitors Market Size Market Share by Application (2019-2024)
Figure 46. Egypt PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries PDGFR Inhibitors Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 52. APAC PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 53. Europe PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 55. United States PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 56. Canada PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 57. Mexico PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 58. Brazil PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 59. China PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 60. Japan PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 61. Korea PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 63. India PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 64. Australia PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 65. Germany PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 66. France PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 67. UK PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 68. Italy PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 69. Russia PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 70. Egypt PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 71. South Africa PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 72. Israel PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 73. Turkey PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries PDGFR Inhibitors Market Size 2025-2030 ($ millions)
Figure 75. Global PDGFR Inhibitors Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global PDGFR Inhibitors Market Size Market Share Forecast by Application (2025-2030)